Michael H. Goldstein Insider Trading
Get free email notifications about insider trading for Michael H. Goldstein.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Michael H. Goldstein. Michael H. Goldstein is a Chief Medical Officer in APPLIED GENETIC TECHNOLOGIES CORP ($AGTC) and a Chief Medical Officer in OCULAR THERAPEUTIX, INC ($OCUL) and a President, Ophthalmology & CMO in OCULAR THERAPEUTIX, INC ($OCUL).
Address: C/O APPLIED GENETIC TECHNOLOGIES CORP. 14193 NW 119TH TERRACE, SUITE #10 ALACHUA 32615 FL
Companies in which Michael H. Goldstein is an Insider
APPLIED GENETIC TECHNOLOGIES CORP
Trading Symbol: AGTCIndustry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Michael H. Goldstein: Chief Medical Officer
Holdings: 0 shares
Current Value: $0
Latest Transaction: Jul 18 2017
$AGTC Market Capitalization: $115.53M
$AGTC Previous Close: $6.45
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
OCULAR THERAPEUTIX, INC
Trading Symbol: OCULIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Michael H. Goldstein: President, Ophthalmology & CMO, Chief Medical Officer
Holdings: 25,686 shares
Current Value: $177,490
Latest Transaction: Feb 19 2021
$OCUL Market Capitalization: $171.42M
$OCUL Previous Close: $6.91
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Michael H. Goldstein
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Feb 19 2021 | OCUL | OCULAR THERAPEUTIX ... | Goldstein Michael H. | President, Ophthalm ... | Option Exercise | A | 18.31 | 250,000 | 4,577,500 | 250,000 | |
Feb 03 2020 | OCUL | OCULAR THERAPEUTIX ... | Goldstein Michael H. | Chief Medical Offic ... | Option Exercise | A | 4.39 | 215,000 | 943,850 | 215,000 | |
May 30 2019 | OCUL | OCULAR THERAPEUTIX ... | Goldstein Michael H. | Chief Medical Offic ... | Buy | P | 2.51 | 12,000 | 30,120 | 25,686 | 13.7 K to 25.7 K (+87.68 %) |
Mar 18 2019 | OCUL | OCULAR THERAPEUTIX ... | Goldstein Michael H. | Chief Medical Offic ... | Buy | P | 4.15 | 10,000 | 41,500 | 13,686 | 3.7 K to 13.7 K (+271.30 %) |
Jan 04 2019 | OCUL | OCULAR THERAPEUTIX ... | Goldstein Michael H. | Chief Medical Offic ... | Option Exercise | A | 4.10 | 150,000 | 615,000 | 150,000 | |
Jul 18 2017 | AGTC | APPLIED GENETIC TE ... | Goldstein Michael H. | Chief Medical Offic ... | Option Exercise | A | 4.90 | 25,000 | 122,500 | 25,000 | |
Dec 02 2016 | AGTC | APPLIED GENETIC TE ... | Goldstein Michael H. | Chief Medical Offic ... | Option Exercise | A | 8.70 | 180,000 | 1,566,000 | 180,000 |